SoundHound AI's COO Sells 65K Shares

01:18pm, Tuesday, 23'rd Jun 2026
The COO sold 64,994 shares, representing a transaction value of approximately ~$485,000. This sale accounted for 3.7% of Michael Zagorsek's equity holdings.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min
SpaceX's COO Gwynne Shotwell didn't dismiss the possibility of a tie-up with Tesla, Elon Musk's other trillion-dollar public company. A tie-up "might make Elon's life a little easier," Shotwell told C
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Cooper Companies, Inc. remains a Hold as valuation nears attractive levels but litigation risk and mixed profitability warrant caution. Revenue growth is robust, particularly in the CooperVision s
Whitehead sold 3,901 shares for a total transaction value of approximately ~$828K on June 3, 2026. This sale represented 27.37% of Whitehead's direct holdings prior to the transaction, reducing his di
Evaluate The Cooper Companies' (COO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
The Cooper Companies (COO) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $0.96 per share a year ago.
SAN RAMON, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April
CooperVision momentum and MyDay/MiSight adoption are likely to fuel COO's Q2, but Japan softness and fertility uncertainty remain key watch points.
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both The Cooper Companies (COO) and Straumann Holding AG (SAUHY). But which of these two stocks is more attractiv
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors interested in Medical - Dental Supplies stocks are likely familiar with The Cooper Companies (COO) and Straumann Holding AG (SAUHY). But which of these two stocks is more attractive to value
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE